Nitzan Shmuel

Title: Nitzan Shmuel: Innovator in Androgen-Dependent Disorder Treatments

Introduction

Nitzan Shmuel is a notable inventor based in Nofit, Israel. He has made significant contributions to the field of medical treatments, particularly focusing on androgen-dependent disorders. His innovative work has led to the development of a unique patent that addresses these health issues.

Latest Patents

Nitzan Shmuel holds a patent for a composition and method for treating androgen-dependent disorders. This patent, titled "Composition and method for treating androgen-dependent disorders," involves chimeric polypeptides that include a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3α-HSD), fused to a signal peptide moiety. The invention also encompasses polynucleotides encoding the chimeric polypeptide and compositions that include at least one microorganism cell capable of secreting the chimeric polypeptide. The methods and kits provided aim to treat, prevent, or ameliorate androgen-dependent disorders, including androgenic alopecia. Nitzan Shmuel has 1 patent to his name.

Career Highlights

Nitzan Shmuel is associated with the Technion Research & Development Foundation Limited, where he continues to advance his research and innovations. His work is characterized by a commitment to improving health outcomes for individuals affected by androgen-dependent conditions.

Collaborations

Throughout his career, Nitzan has collaborated with talented individuals such as Roee Amit and Alexey Tomsov. These partnerships have contributed to the success of his research and the development of his patent.

Conclusion

Nitzan Shmuel is a pioneering inventor whose work in treating androgen-dependent disorders showcases his dedication to medical innovation. His contributions are poised to make a significant impact in the field of healthcare.